Abstract:Tuberculosis (TB), induced by the foxy Mycobacterium tuberculosis (Mtb), is still one of the top killers worldwide among infectious diseases. Although several antibiotics have been developed to significantly relieve the tuberculosis epidemics worldwide, there are still several important scientific challenges for tuberculosis. As one of the most critical issues for tuberculosis control, the accurate and timely diagnosis of tuberculosis is critical for the following therapy of tuberculosis and thus responsible for the effective control of drug-resistant tuberculosis. Current tuberculosis diagnostic methods in clinic are still facing the difficulties that they can't provide the rapid diagnostic results with high sensitivity and accuracy, which therefore requires the development of more effective novel diagnostic strategies. In recent decades, nanomaterials have been proved to show promising potentials for novel nanobiosensor construction based on their outstanding physical, chemical and biological properties. Taking these promising advantages, nanomaterial-based biosensors show the potential to allow the rapid, sensitive and accurate tuberculosis diagnosis. Here, aiming to increase the development of more effective tuberculosis diagnostic strategy, we summarized the current progress of nanobiosensors for potential tuberculosis diagnosis application. We discussed the different kind diagnostic targets for tuberculosis diagnosis based on nanobiosensors, ranging from the detection of bacterial components from M. tuberculosis, such as DNA and proteins, to the host immunological responses, such as specific cytokine production, and to the direct whole cell detection of M. tuberculosis. We believe that this review would enhance our understandings of nanobiosensors for potential tuberculosis diagnosis, and further promote the future research on nanobiosensor-based tuberculosis diagnosis to benefit the more effective control of tuberculosis epidemic.

Point-of-care Assays for Tuberculosis: Role of Nanotechnology/microfluidics

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.

Microfluidics as a Novel Technique for Tuberculosis: From Di-agnostics to Drug Discovery

Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management

Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests

Application of Nanodiagnostics in Point-of-care Tests for Infectious Diseases

Advances in Nanomaterials and Their Applications in Point of Care (POC) Devices for the Diagnosis of Infectious Diseases.

Towards Accurate Point-of-Care Tests for Tuberculosis in Children

Design of an Efficient, Ease-of-use and Affordable Artificial Intelligence based Nucleic Acid Amplification Diagnosis Technology for Tuberculosis and Multi-drug Resistant Tuberculosis

A finger-driven disposable micro-platform based on isothermal amplification for the application of multiplexed and point-of-care diagnosis of tuberculosis

Advances in Addressing Technical Challenges of Point-of-care Diagnostics in Resource-Limited Settings

Harnessing Nanotechnology to Create New Diagnostics and Treatments for Infectious Disease

Progression in Point-of-Care Testing for Tuberculosis

Current progress of functional nanobiosensors for potential tuberculosis diagnosis: The novel way for TB control?

Microchip-based Ultrafast Serodiagnostic Assay for Tuberculosis

Microfluidic Chip-based Enrichment and Nucleic Acid Extraction for Quantitative Detection of Mycobacterium Smegmatis in Aerosols

Smartphone-based point-of-care multiplexed-genes detection of Mycobacterium tuberculosis on a low-cost paper/polymer hybrid microfluidic device

Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use

Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care